Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Oct:160:105055.
doi: 10.1016/j.phrs.2020.105055. Epub 2020 Jun 30.

Edaravone: A potential treatment for the COVID-19-induced inflammatory syndrome?

Sandra E Reznik  1 , Amit K Tiwari  2 , Charles R Ashby Jr  3
Affiliations
Comment

Edaravone: A potential treatment for the COVID-19-induced inflammatory syndrome?

Sandra E Reznik et al. Pharmacol Res. 2020 Oct.
No abstract available

PubMed Disclaimer

Conflict of interest statement

None of the authors has any declaration of interest.

Comment on

References

    1. Zhong H., Wang Y., Zhang Z.-L., Liu Y.-X., Le K.-J., Cui M., Yu Y.-T., Gu Z.-C., Gao Y., Lin H.-W. Efficacy and safety of current therapeutic options for COVID-19 – lessons to be learnt from SARS and MERS epidemic: a systematic review and meta-analysis. Pharmacol. Res. 2020;157 - PMC - PubMed
    1. Huang C., Wang X., Li L., Ren L., Zhao J., Hu Y., Zhang L., Fan G., Xu J., Gu X., Cheng Z., Yu T., Xia J., Wei Y., Wu W., Xie X., Yin W., Li H., Liu M., Xiao Y., Gao H., Guo L., Xie J., Wang G., Jiang R., Gao Z., Jin Q., Wang J., Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. - PMC - PubMed
    1. Watanabe T., Tahara M., Todo S. The novel antioxidant edaravone: from bench to bedside. Cardiovasc. Ther. 2008;26(2):101–114. - PubMed
    1. Kikuchi K., Takeshige N., Miura N., Morimoto Y., Ito T., Tancharoen S., Miyata K., Kikuchi C., Iida N., Uchikado H., Miyagi N., Shiomi N., Kuramoto T., Maruyama I., Morioka M., Kawahara K.-I. Beyond free radical scavenging: beneficial effects of edaravone (Radicut) in various diseases (Review) Exp. Ther. Med. 2012;3(1):3–8. - PMC - PubMed
    1. Chen G., Wu D., Guo W., Cao Y., Huang D., Wang H., Wang T., Zhang X., Chen H., Yu H., Zhang X., Zhang M., Wu S., Song J., Chen T., Han M., Li S., Luo X., Zhao J., Ning Q. Clinical and immunological features of severe and moderate coronavirus disease. J. Clin. Invest. 2020;130(5):2620–2629. - PMC - PubMed